Pharma Focus America

LATEST NEWSRead more...

26

Jul 2024

Nectin Therapeutics Grants Immunome License for Novel Antibodies

Nectin Therapeutics Ltd a biotechnology company focused on developing innovative immunotherapies and antibody drug conjugates to overcome tumor resistance has announced an exclusive global licensing agreement with Immunome Inc a biotechnology firm dedicated to creating cuttingedge cancer treatments

26

Jul 2024

AC Immune's JNJ-2056 (formerly ACI-35.030) Receives FDA Fast Track Status for Alzheimer's Disease

AC Immune SA a biopharmaceutical company focused on neurodegenerative diseases has announced that its candidate for active immunotherapy ACI targeting the pathological

25

Jul 2024

M8 Pharmaceuticals and LG Chem Forge Exclusive Agreement to Launch Innovative Type 2 Diabetes and Osteoarthritis Therapies in Latin America

M Pharmaceuticals a subsidiary of Acino has entered into an exclusive licensing and distribution agreement with LG Chem Ltd a prominent life sciences company based in South Korea

25

Jul 2024

INIMMUNE Begins Phase 1 Clinical Trial of INI-4001, a New TLR7/8 Agonist for Cancer Therapy

Inimmune a clinicalstage biotech company dedicated to advancing novel immunotherapies vaccines and adjuvants has announced the launch of its Phase clinical trial for INI This trial marking

25

Jul 2024

Eclipsebio Launches eMERGE™ Platform, Offering Comprehensive Solutions for RNA-Based Therapeutic Product Characterization and Optimization

Eclipse Bioinnovations Inc has launched its cuttingedge eMERGE platform designed to revolutionize the development of RNAbased therapeutics This advanced platform provides a complete solution

24

Jul 2024

Orange Grove Bio and the University of Chicago Collaborate to Drive Innovation and Commercialization in Biotechnology

Orange Grove Bio a leading biopharmaceutical company has teamed up with the University of Chicagos Polsky Center for Entrepreneurship and Innovation to drive the commercialization

press releasesRead more...

Actinium Receives FDA Clearance for Iomab-ACT Targeted Conditioning IND for Sickle Cell Disease

Actinium Pharmaceuticals Inc a leader in the development of Antibody Radiation Conjugates and other targeted radiotherapies today announced the FDA clearance of an Investigational New Drug application to study IomabACT for targeted

Ipsen and Day One Enter into Exclusive Non-U.S. Licensing Agreement to Commercialize Tovorafenib for the Most Common Form of Pediatric Brain Tumor

Ipsen and Day One Biopharmaceuticals today announced a global partnership agreement outside the United States for tovorafenib in GBG the most common form of childhood brain cancer and any future indications developed

ITF Therapeutics LLC Announces U.S. Commercial Availability of DUVYZAT™ (givinostat) for Treatment of Patients With Duchenne Muscular Dystrophy

ITF Therapeutics LLC the USbased rare disease commercial arm of Italfarmaco today announced the US commercial launch of DUVYZAT givinostat a histone deacetylase inhibitor for the treatment of patients

29 - 31

Jul 2024

29 - 31

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

15 - 16

Aug 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

20 - 22

Aug 2024

21 - 22

Aug 2024
Testing The WorldCelebrating 70 Years of Nalgene
Thermo Fisher Scientific - mRNA Services
Future Labs Live USA 2024
World Vaccine Congress Europe 2024
World Orphan Drug Congress 2024
Advanced Therapies USA 2024
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 1

    From Miracle Drugs to Superbugs: Understanding Antimicrobial Resistance

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 2

    The Role of mRNA Technology Beyond COVID-19 Vaccines: A New Era in Medicine

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    Data Analytics and Forecasting in Pharmaceutical Distribution

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    Addressing the Opioid Crisis: The Role of Pharmaceutical Companies

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 5

    The Future of Pharma: Integrating Imaging Informatics for Better Outcomes

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

  • Techno Trends

    Pfizer Discovers Novel Nasal Spray for the Treatment of Migraine

    Pfizer has developed ZAVZPRET zavegepant the first and only new CGRP receptor antagonist nasal spray for the acute management of adult migraines The US Food and Drug Administration FDA has given this spray its approval An oral and intranasal formulation of zavegepant a thirdgeneration selective and structurally

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues